Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its ...

Becton, Dickinson plans to reduce debt and repurchase $1B in shares. Read why BDX stock is a solid Buy, enhancing financial ...

Becton, Dickinson & Co. is a New Jersey-based medical technology company. The company develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products used by ...

Crossmark Global Holdings Inc. boosted its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 1.8% during ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Josh Jennings, an analyst from TD Cowen, maintained the Hold rating on Becton Dickinson (BDX – Research Report). The associated price ...

BD's Q4 sales rose 6.9% to $5.44 billion, beating estimates. EPS of $3.81 also topped forecasts. FY25 guidance includes $21.9 ...

Report with market evolution powered by AI - The global disposable medical supplies market size is estimated to grow by USD 604.17 billion from 2024-2028, according to Technavio. The market is ...

Axxcess Wealth Management LLC raised its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 6.0% in the ...

Bengaluru: Becton Dickinson surpassed analysts' expectations ... Becton manufactures and distributes medical and surgical products such as needles, syringes and disposal units.